BACKGROUND: The ongoing shortage of donor livers for transplantation and the increased use of marginal livers necessitate the development of accurate pretransplant tests of viability. Considering the importance energy status during transplantation, we aimed to correlate peritransplant energy cofactors to posttransplant outcome and subsequently model this in an ex vivo setting. METHODS: Sequential biopsies were taken from 19 donor livers postpreservation, as well as 30 minutes after portal venous reperfusion and hepatic arterial reperfusion and analyzed by liquid chromatography-mass spectrometry for energetic cofactors (adenosine triphosphate [ATP]/adenosine diphosphate [ADP]/adenosine monophosphate [AMP], nicotinamide adenine dinucleotide /NAD, nicotinamide adenine dinucleotide phosphate / nicotinamide adenine dinucleotide phosphate , flavin adenine dinucleotide , glutathione disulfide/glutathione). Energy status was correlated to posttransplant outcome. In addition, 4 discarded human donation after circulatory death livers were subjected to ex vivo reperfusion, modeling reperfusion injury and were similarly analyzed for energetic cofactors. RESULTS: A rapid shift toward higher energy adenine nucleotides was observed following clinical reperfusion, with a 2.45-, 3.17- and 2.12-fold increase in ATP:ADP, ATP:AMP and energy charge after portal venous reperfusion, respectively. Seven of the 19 grafts developed early allograft dysfunction. Correlation with peritransplant cofactors revealed a significant difference in EC between early allograft dysfunction and normal functioning grafts (0.09 vs 0.31, P < 0.05). In the simulated reperfusion model, a similar trend in adenine nucleotide changes was observed. CONCLUSIONS: A preserved energy status appears critical in the peritransplant period. Levels of adenine nucleotides change rapidly after reperfusion and ratios of ATP/ADP/AMP after reperfusion are significantly correlated to graft function. Using these markers as a viability test in combination with ex vivo reperfusion may provide a useful predictor of outcome that incorporates donor, preservation, and reperfusion factors.
BACKGROUND: The ongoing shortage of donor livers for transplantation and the increased use of marginal livers necessitate the development of accurate pretransplant tests of viability. Considering the importance energy status during transplantation, we aimed to correlate peritransplant energy cofactors to posttransplant outcome and subsequently model this in an ex vivo setting. METHODS: Sequential biopsies were taken from 19 donor livers postpreservation, as well as 30 minutes after portal venous reperfusion and hepatic arterial reperfusion and analyzed by liquid chromatography-mass spectrometry for energetic cofactors (adenosine triphosphate [ATP]/adenosine diphosphate [ADP]/adenosine monophosphate [AMP], nicotinamide adenine dinucleotide /NAD, nicotinamide adenine dinucleotide phosphate / nicotinamide adenine dinucleotide phosphate , flavin adenine dinucleotide , glutathione disulfide/glutathione). Energy status was correlated to posttransplant outcome. In addition, 4 discarded human donation after circulatory death livers were subjected to ex vivo reperfusion, modeling reperfusion injury and were similarly analyzed for energetic cofactors. RESULTS: A rapid shift toward higher energy adenine nucleotides was observed following clinical reperfusion, with a 2.45-, 3.17- and 2.12-fold increase in ATP:ADP, ATP:AMP and energy charge after portal venous reperfusion, respectively. Seven of the 19 grafts developed early allograft dysfunction. Correlation with peritransplant cofactors revealed a significant difference in EC between early allograft dysfunction and normal functioning grafts (0.09 vs 0.31, P < 0.05). In the simulated reperfusion model, a similar trend in adenine nucleotide changes was observed. CONCLUSIONS: A preserved energy status appears critical in the peritransplant period. Levels of adenine nucleotides change rapidly after reperfusion and ratios of ATP/ADP/AMP after reperfusion are significantly correlated to graft function. Using these markers as a viability test in combination with ex vivo reperfusion may provide a useful predictor of outcome that incorporates donor, preservation, and reperfusion factors.
Authors: B G Bruinsma; H Yeh; S Ozer; P N Martins; A Farmer; W Wu; N Saeidi; S Op den Dries; T A Berendsen; R N Smith; J F Markmann; R J Porte; M L Yarmush; K Uygun; M-L Izamis Journal: Am J Transplant Date: 2014-04-23 Impact factor: 8.086
Authors: W R Kim; J R Lake; J M Smith; M A Skeans; D P Schladt; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2015-01 Impact factor: 8.086
Authors: Kim M Olthoff; Laura Kulik; Benjamin Samstein; Mary Kaminski; Michael Abecassis; Jean Emond; Abraham Shaked; Jason D Christie Journal: Liver Transpl Date: 2010-08 Impact factor: 5.799
Authors: Andrie C Westerkamp; Paria Mahboub; Sophie L Meyer; Maximilia Hottenrott; Petra J Ottens; Janneke Wiersema-Buist; Annette S H Gouw; Ton Lisman; Henri G D Leuvenink; Robert J Porte Journal: Liver Transpl Date: 2015-10 Impact factor: 5.799
Authors: Sinem Perk; Maria-Louisa Izamis; Herman Tolboom; Basak Uygun; Francois Berthiaume; Martin L Yarmush; Korkut Uygun Journal: PLoS One Date: 2011-12-14 Impact factor: 3.240
Authors: Bote G Bruinsma; Gautham V Sridharan; Pepijn D Weeder; James H Avruch; Nima Saeidi; Sinan Özer; Sharon Geerts; Robert J Porte; Michal Heger; Thomas M van Gulik; Paulo N Martins; James F Markmann; Heidi Yeh; Korkut Uygun Journal: Sci Rep Date: 2016-03-03 Impact factor: 4.379
Authors: Laura C Burlage; Alexandre G Lellouch; Corentin B Taveau; Philipp Tratnig-Frankl; Casie A Pendexter; Mark A Randolph; Robert J Porte; Laurent A Lantieri; Shannon N Tessier; Curtis L Cetrulo; Korkut Uygun Journal: J Surg Res Date: 2021-10-17 Impact factor: 2.192
Authors: Shannon N Tessier; Reinier J de Vries; Casie A Pendexter; Stephanie E J Cronin; Sinan Ozer; Ehab O A Hafiz; Siavash Raigani; Joao Paulo Oliveira-Costa; Benjamin T Wilks; Manuela Lopera Higuita; Thomas M van Gulik; Osman Berk Usta; Shannon L Stott; Heidi Yeh; Martin L Yarmush; Korkut Uygun; Mehmet Toner Journal: Nat Commun Date: 2022-07-15 Impact factor: 17.694
Authors: Irene Beijert; Safak Mert; Viola Huang; Negin Karimian; Sharon Geerts; Ehab O A Hafiz; James F Markmann; Heidi Yeh; Robert J Porte; Korkut Uygun Journal: Transplant Direct Date: 2018-04-23
Authors: Reinier J de Vries; Shannon N Tessier; Peony D Banik; Sonal Nagpal; Stephanie E J Cronin; Sinan Ozer; Ehab O A Hafiz; Thomas M van Gulik; Martin L Yarmush; James F Markmann; Mehmet Toner; Heidi Yeh; Korkut Uygun Journal: Nat Protoc Date: 2020-05-20 Impact factor: 13.491
Authors: Jordan J Nostedt; Tom Churchill; Sunita Ghosh; Aducio Thiesen; Jessica Hopkins; Mackenzie C Lees; Benjamin Adam; Darren H Freed; A M James Shapiro; David L Bigam Journal: PLoS One Date: 2019-08-06 Impact factor: 3.240
Authors: Reinier J de Vries; Shannon N Tessier; Peony D Banik; Sonal Nagpal; Stephanie E J Cronin; Sinan Ozer; Ehab O A Hafiz; Thomas M van Gulik; Martin L Yarmush; James F Markmann; Mehmet Toner; Heidi Yeh; Korkut Uygun Journal: Nat Biotechnol Date: 2019-09-09 Impact factor: 54.908
Authors: Viola Huang; Negin Karimian; Danielle Detelich; Siavash Raigani; Sharon Geerts; Irene Beijert; Fermin M Fontan; Mohamed M Aburawi; Sinan Ozer; Peony Banik; Florence Lin; Murat Karabacak; Ehab O A Hafiz; Robert J Porte; Korkut Uygun; James F Markmann; Heidi Yeh Journal: J Clin Med Date: 2020-01-18 Impact factor: 4.241